organization · Reporting owner
Nippon Shinyaku Co Ltd
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAPRICOR THERAPEUTICS, INC.CAPR · Entity 5337 | 10% owner | September 20, 2024 | September 24, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAPRICOR THERAPEUTICS, INC.
Report date September 20, 2024 · Filed September 24, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 7,090,351 |
Reported balance
After 2024-09-20 transaction · row 1
1 source rowRow 1 · 2024-09-20 · Purchase · Acquired 2,798,507 · Balance 7,090,351 F1: On September 20, 2024, Capricor Therapeutics, Inc., a Delaware corporation (the "Issuer") issued 2,798,507 shares of common stock, $0.001 par value per share (the "Common Stock") to Nippon Shinyaku Co Ltd (the "Reporting Person"), acquired in a private placement pursuant to the terms and conditions of a Subscription Agreement, dated as of September 16, 2024, between the Reporting Person and the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 20, 2024, Capricor Therapeutics, Inc., a Delaware corporation (the "Issuer") issued 2,798,507 shares of common stock, $0.001 par value per share (the "Common Stock") to Nippon Shinyaku Co Ltd (the "Reporting Person"), acquired in a private placement pursuant to the terms and conditions of a Subscription Agreement, dated as of September 16, 2024, between the Reporting Person and the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2024 Filed Sep 24, 2024 20:01 UTC | CAPRICOR THERAPEUTICS, INC. CAPR · Entity 5337 | PurchaseCommon Stock, par value $0.001 per share | 2,798,507 | $5.36 | $14,999,997.52 |
DisclosureSEC source: 0000929638-24-003214 · form4.xml · nonDerivative · entry 1 Nippon Shinyaku Co Ltd · CIK 0001361865 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,090,351 F1 · shares: On September 20, 2024, Capricor Therapeutics, Inc., a Delaware corporation (the "Issuer") issued 2,798,507 shares of common stock, $0.001 par value per share (the "Common Stock") to Nippon Shinyaku Co Ltd (the "Reporting Person"), acquired in a private placement pursuant to the terms and conditions of a Subscription Agreement, dated as of September 16, 2024, between the Reporting Person and the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.